ProQR Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $4,307 | $3,843 | $6,336 | $4,476 |
Gross Profit | 4,307 | 3,843 | 5,622 | 3,781 |
EBITDA | -5,821 | -8,166 | -3,045 | -7,384 |
EBIT | -6,492 | -8,854 | -3,756 | -8,079 |
Net Income | -9,305 | -8,108 | -2,692 | -7,703 |
Net Change In Cash | 4,307 | 3,843 | 6,336 | 4,476 |
Free Cash Flow | -9,481 | -5,943 | -6,523 | -15,957 |
Cash | 149,408 | 89,401 | 78,970 | 85,792 |
Basic Shares | 81,665 | 81,665 | 81,665 | 81,571 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $18,905 | $6,514 | $4,037 | $1,354 |
Gross Profit | 18,905 | 6,380 | 1,561 | 1,354 |
EBITDA | -24,122 | -24,097 | -56,460 | -54,948 |
EBIT | -26,883 | -26,610 | -58,935 | -57,369 |
Net Income | -27,763 | -28,119 | -64,891 | -61,680 |
Net Change In Cash | 18,905 | 6,514 | 4,037 | 1,354 |
Free Cash Flow | -37,811 | 20,177 | -69,216 | -26,496 |
Cash | 149,408 | 118,925 | 94,775 | 187,524 |
Basic Shares | 81,665 | 81,011 | 71,641 | 64,182 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.09 |
2024-09-30 | -$0.07 |
2024-06-30 | -$0.03 |
2024-03-31 | -$0.09 |
